Curran Financial Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$327K Buy
2,721
+41
+2% +$4.73K 0.06% 98
2025
Q4
$282K Sell
2,680
-99
-4% -$9.29K 0.05% 105
2025
Q3
$233K Sell
2,779
-55
-2% -$4.53K 0.05% 120
2025
Q2
$224K Sell
2,834
-222
-7% -$17.6K 0.05% 111
2025
Q1
$274K Buy
+3,056
New +$285K 0.07% 81
2024
Q4
Sell
-2,076
Closed -$236K 98
2024
Q3
$236K Buy
2,076
+134
+7% +$15.9K 0.07% 83
2024
Q2
$240K Buy
1,942
+37
+2% +$4.77K 0.08% 79
2024
Q1
$251K Hold
1,905
0.09% 73
2023
Q4
$227K Buy
+1,905
New +$198K 0.09% 73
2023
Q3
Sell
-1,921
Closed -$222K 79
2023
Q2
$222K Sell
1,921
-1
-0.1% -$114 0.1% 69
2023
Q1
$204K Buy
+1,922
New +$208K 0.1% 64

Other funds holding MRK

Curran Financial Partners's MRK Position: Q1 2026 in Review

Curran Financial Partners increased its Merck (MRK) stake by 1.5% in Q1 2026, buying an estimated $4.73K and bringing the position to 2,721 shares worth $327K. The position accounts for 0.06% of the portfolio, ranked #98.

Curran Financial Partners first reported a position in MRK in Q1 2023 and has held it in 11 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Curran Financial Partners held 2,721 shares of Merck worth $327K as of Q1 2026.
  • Curran Financial Partners bought 41 Merck shares in Q1 2026, an estimated $4.73K.
  • Merck made up 0.06% of Curran Financial Partners's portfolio in Q1 2026, its #98 holding.
  • Curran Financial Partners first reported a position in Merck in Q1 2023 and has held it in 11 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Curran Financial Partners's 13F filing for Q1 2026, filed 15 Apr 2026.